Biocon Limited (BIOCON): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Biocon Limited, explained in plain English.

• ▪Biocon Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪BIOCON closed at ₹351.90 on 29 October 2026.
• ▪Over the past year the shares are down 5.8%, trading between ₹318.40 and ₹447.15.
• ▪Reported fundamentals show a net margin of 2.86%, debt to equity of 42.15.
• ▪Our transparent MaxGrade checklist scores it F (30/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 25.88% with a maximum drawdown of -26.59% and a beta of 0.68 against NIFTY 50.
• ▪Recent coverage: Midcap 100, Smallcap 100 index down 1%; MRF, Biocon, Swiggy at 52-week lows

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Last traded values from 29 Oct 2026. Market opens at 9:15 IST.